Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

NCT00077012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: QLT0074
DRUG: Photodynamic therapy

Sponsor

QLT Inc.